ProAxsis signs partnership agreement with US based Biotechnology company to develop two key respiratory proteases, utilizing ProteaseTag® technology, a platform technology that allows any protease to be targeted

Recent Posts

Have Any Questions?

Contact Us

PR8
Share This :